Statutory Targets definition

Statutory Targets means the targets for composting and recycling of Household Waste as set out in Waste Strategy for England 2007;
Sample 1Sample 2Sample 3
Statutory Targets means the targets for composting and recycling of Household
Sample 1
Statutory Targets. [the Recycling and Composting targets for the purposes of BVPI 82 (a) and (b) and landfill division targets for the purposes of the WET Act]
Sample 1

Examples of Statutory Targets in a sentence

  • To these ends, the Partners shall work together to achieve Statutory Targets, landfill permit levels and local targets agreed jointly in the Joint Municipal Waste Management Strategy or any future targets that have been jointly agreed, and as far as is reasonable or practicable, to reduce the detrimental impact on the Partners and council tax payers of any one of them failing to carry out its obligations under this Agreement.

  • Statutory Targets Recycling and composting targets for the purposes of BVPI 82 (a) and (b) and landfill diversion targets for the purposes of the WET Act Tipping Away Payments Payment made by County to District, when the County directs a District to take waste to a Disposal Point that is not the usual Disposal Point and is unreasonably far from the usual Disposal Point, as a result of the usual Disposal Point being unavailable for the reception of Contract Waste, as set out in EPA 1990, Section 52.

  • Statutory Targets Recycling and compostingtargets for the purposes of BVPI 82 (a) and (b) and landfill diversion targets for the Tipping Away Paymentspurposes of the WET Act Payment made by County to District, when the County directs a District to take waste to a Disposal Point that is not the usual Disposal Point and is unreasonably far from the Districts area, as a result of the usual Disposal Point being unavailable for the reception of Contract Waste, as set out in EPA 1990, Section 52.

  • The 1999 Landfill Directive (99/31/EC) requires all local authorities to divert prescribed amounts of biodegradable municipal waste from Landfill and this is enforced by the Waste Emissions and Trading Xxx 0000 (together the NIs and landfill diversion requirements shall be known as the Statutory Targets).

  • The key drivers are: • National policy initiatives to decrease the amount of waste disposed to landfill, including the introduction of the Landfill Allowance Trading Scheme (LATS), and increasing levels of landfill tax, which will significantly increase the cost of this method of disposal;• Statutory Targets for Recycling and Composting, which are reported as best value performance indicators;• Changes in legislation and guidance, and a shift in public demands and perceptions of waste management.

  • Statutory Targets Recycling and composting targets for the purposes of BVPI 82 (a) and (b) and landfill diversion targets for the purposes of the WET Act Tipping Away Payments Payment made by County to District, when the County directs a District to take waste to a Disposal Point that is not the usual Disposal Point and is unreasonably far from the Districts area, as a result of the usual Disposal Point being unavailable for the reception of Contract Waste, as set out in EPA 1990, Section 52.

  • Without prejudice to the generality of clause 15.1, and save for the matters expressly referred to in Schedule 4 (Payment and Compensation Mechanism), each WCA shall be responsible for its own costs and expenses in relation to: maintaining the WCA Baseline; and achieving the Statutory Targets applicable to it from time to time during the Term.

  • Reason: (1)To continue to provide the kerbside collection service and to meetthe operating costs of the service.(2)To work towards the Council meeting its Statutory Targets and build towards targets for 2005-2006.

  • Table II.B-2 provides examples of the additional volumes that would be needed if the 2017 statutory target for total renewable fuel were not waived.Examples of Fuel Types Needed to Meet the Statutory Targets for Total Renewable Fuel in 2017 (million physical gallons of fuel unless otherwise noted)Additional volumes needed (ethanol-equivalent)a Although E85 is assumed to contain 74% ethanol, the use of E85 also displaces some E10.

  • Applicant Self Assessment:New EvidenceNot Rated PRS082: Food Standards Statutory Targets & Performance.

Related to Statutory Targets

  • Targets means pre-agreed values to be achieved at the end of the period in relation to the result indicators included under a specific objective;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • ASAM criteria means admission, continued service, transfer, and discharge criteria for the treatment of substance use disorders as published by the American Society of Addiction Medicine (ASAM).

  • Soft Target means a target that will suffer minimum damage and cause minimum damage to the subject vehicle in the event of a collision.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Performance Targets means the specific objective goal or goals (which may be cumulative and/or alternative) that are timely set in writing by the Committee for each Executive for the Performance Period in respect of any one or more of the Business Criteria.

  • Business Criteria means any one or any combination of Income before Taxes, Net Income, Return on Equity, Return on Assets, Pre-tax Margin, Free Cash Flow, Valuation or EPS.

  • Acquisition Target means any Person becoming a Subsidiary of the Company after the date hereof; any Person that is merged into or consolidated with the Company or any Subsidiary of the Company after the date hereof; or any Person with respect to which all or a substantial part of that Person’s assets are acquired by the Company or any Subsidiary of the Company after the date hereof.

  • Performance Target means the level of performance expected of the HSP in respect of a Performance Indicator or a Service Volume; “person or entity” includes any individual and any corporation, partnership, firm, joint venture or other single or collective form of organization under which business may be conducted;

  • Over-Riding Nomination Criteria means the criteria set out in clause 4.2.

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Performance Measure means one or more of the following selected by the Committee to measure Company, Affiliate, and/or business unit performance for a Performance Period, whether in absolute or relative terms (including, without limitation, terms relative to a peer group or index): basic, diluted, or adjusted earnings per share; sales or revenue; earnings before interest, taxes, and other adjustments (in total or on a per share basis); basic or adjusted net income; returns on equity, assets, capital, revenue or similar measure; economic value added; working capital; total shareholder return; and product development, product market share, research, licensing, litigation, human resources, information services, mergers, acquisitions, sales of assets of Affiliates or business units. Each such measure shall be, to the extent applicable, determined in accordance with generally accepted accounting principles as consistently applied by the Company (or such other standard applied by the Committee) and, if so determined by the Committee, and in the case of a Performance Compensation Award, to the extent permitted under Code Section 162(m), adjusted to omit the effects of extraordinary items, gain or loss on the disposal of a business segment, unusual or infrequently occurring events and transactions and cumulative effects of changes in accounting principles. Performance Measures may vary from Performance Period to Performance Period and from Participant to Participant, and may be established on a stand-alone basis, in tandem or in the alternative.

  • Performance Measurement Period has the meaning set forth in Section 3.1(e)(ii).

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Board-Established Criteria means criteria that the Board of a Regulated Fund may establish from time to time to describe the characteristics of Potential Co-Investment Transactions regarding which the Adviser to the Regulated Fund should be notified under Condition 1. The Board-Established Criteria will be consistent with the Regulated Fund’s Objectives and Strategies (defined below). If no Board-Established Criteria are in effect, then the Regulated Fund’s Adviser will be notified of all Potential Co-Investment Transactions that fall within the Regulated Fund’s then-current Objectives and Strategies. Board-Established Criteria will be objective and testable, meaning that they will be based on observable information, such as industry/sector of the issuer, minimum EBITDA of the issuer, asset class of the investment opportunity or required commitment size, and not on characteristics that involve a discretionary assessment. The Adviser to the Regulated Fund may from time to time recommend criteria for the Board’s consideration, but Board-Established Criteria will only become effective if approved by a majority of the Independent Directors (defined below). The Independent Directors of a Regulated Fund may at any time rescind, suspend or qualify their approval of any Board-Established Criteria, though Applicants anticipate that, under normal circumstances, the Board would not modify these criteria more often than quarterly.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Valid write-in candidate means a candidate who has qualified as a write-in

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • Peer-reviewed medical literature means a scientific study published only after having been critically

  • Indicators of student progress and growth means the results of assessment(s) of students as defined in N.J.A.C. 6A:8, Standards and Assessment.

  • Step therapy protocol means a protocol or program that establishes the specific

  • Evaluation Criteria means the criteria set out under the clause 27 (Evaluation Process) of this Part C, which includes the Qualifying Criteria, Functional Criteria and Price and Preferential Points Assessment.

  • Performance Measures means measures as described in Article 12 on which the performance goals are based and which are approved by the Company’s shareholders pursuant to this Plan in order to qualify Awards as Performance-Based Compensation.

  • Annual Net Sales means, with respect to any Calendar Year, the aggregate amount of the Net Sales for such Calendar Year.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.